1Noda K,Nishiwaki Y,Kawahara M,et al.Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer[J].N Engl J Med,2002,346(2):85-91.
2El Maalouf C,Rodier JM,Faivre S,et al.Could we expect to improve survival in small cell lung cancer?[J].Lung Cancer,2007,57(2):30-34.
3Lara PN Jr,Natale R,Cmwler J,et al.PhaseⅢtrial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer:clinical and pharmacogeonmic results from SWOG S0124[J].J Clin Oncol,2009,27(15):2530-2535.
4Hanna N,Bunn PA Jr,Langer C,et al.Randomized phaseⅢtrial comparing irinotecan/cisplatin with etoposede/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer[J].J Clin Oncol,2006,24(13):2038.
5Zatloukal P,Cardenal F,Szozesna A,et al.A multicenter interna-tional randomized phaseⅢstudy comparing Cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease[J].Ann Oncol,2010,12(9):1810-1816.
6Jiang J,Liang X,Zhou X,et al.A Meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensivestage small cell lung cancer[J].J Thorac Oncol,2010,5(6):867-873.
